63 assets in Chemotherapy-Induced Toxicity

Therapeutic assets addressing Chemotherapy-Induced Toxicity, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Dexasone Chemotherapy-Induced Toxicity	Instituto do Cancer do Estado de São Paulo	P4	A (82)
Palonosetron Chemotherapy-Induced Toxicity	Second Affiliated Hospital, School of Medicine, Zhejiang University	P4	A (82)
Phosphonic Acid, P-[3-[[(2R,3R)-2-[(1R)-1-[3,5-Bis(Trifluoromethyl)Phenyl]Ethoxy]-3-(4-Fluorophenyl)-4-Morpholinyl]Methyl]-2,5-Dihydro-5-Oxo-1H-1,2,4-Triazol-1-Yl]- Chemotherapy-Induced Toxicity	Second Affiliated Hospital, School of Medicine, Zhejiang University	P4	BBB (75)
Docetaxel Chemotherapy-Induced Toxicity	The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School	P4	BB (69)
HR20013 Chemotherapy-Induced Toxicity	Fujian Shengdi Pharmaceutical Co., Ltd.	P3	BB (69)
Carboplatin Chemotherapy-Induced Toxicity	Endeavor Health	P3	BB (68)
Adriamycin Chemotherapy-Induced Toxicity	Instituto do Cancer do Estado de São Paulo	P4	BB (65)
Cis-Diamminedichloroplatinum Ii Chemotherapy-Induced Toxicity	Zhiyong Yu	P2/3	BB (65)
Idarubicin Chemotherapy-Induced Toxicity	Fujian Medical University Union Hospital	P4	BB (65)
Prednisone Chemotherapy-Induced Toxicity	Instituto do Cancer do Estado de São Paulo	P4	BB (65)
Cytarabine Chemotherapy-Induced Toxicity	Instituto do Cancer do Estado de São Paulo	P3	BB (64)
Capecitabine Chemotherapy-Induced Toxicity	National Cancer Center Affiliate of Vilnius University Hospital Santaros Klinikos	P3	B (63)
Oxaliplatin Chemotherapy-Induced Toxicity	Linhui Peng	P3	B (63)
Clostridium Butyricum Chemotherapy-Induced Toxicity	The Affiliated Hospital of Qingdao University	P4	B (62)
Cyclophosphamide Chemotherapy-Induced Toxicity	The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School	P4	B (62)
Daunomycin Chemotherapy-Induced Toxicity	Instituto do Cancer do Estado de São Paulo	P4	B (62)
Irinotecan Chemotherapy-Induced Toxicity	Amsterdam UMC, location VUmc	P3	B (62)
Rivoceranib Chemotherapy-Induced Toxicity	Linhui Peng	P3	B (62)
Silybin Chemotherapy-Induced Toxicity	Fujian Medical University Union Hospital	P4	B (62)
Bortezomib Chemotherapy-Induced Toxicity	Hospital General de Mexico	P4	B (61)
Fluorouracilum Chemotherapy-Induced Toxicity	Linhui Peng	P3	B (61)
Methotrexate Chemotherapy-Induced Toxicity	Instituto do Cancer do Estado de São Paulo	P2	B (61)
Thalidomide Chemotherapy-Induced Toxicity	Fudan University	P3	B (61)
Abemaciclib Chemotherapy-Induced Toxicity	Eli Lilly and Company	P3	B (60)
Abiraterone Chemotherapy-Induced Toxicity	Eli Lilly and Company	P3	B (60)
Ophiopogon Japonicus Chemotherapy-Induced Toxicity	Zhejiang Cancer Hospital	P3	B (60)
Prednisolone Chemotherapy-Induced Toxicity	Eli Lilly and Company	P3	B (60)
Schisandra Chinensis Chemotherapy-Induced Toxicity	Zhejiang Cancer Hospital	P3	B (60)
Shengmai San Chemotherapy-Induced Toxicity	Zhejiang Cancer Hospital	P3	B (60)
Cetuximab Chemotherapy-Induced Toxicity	City Clinical Oncology Hospital No 1	P3	B (59)
Tucidinostat Chemotherapy-Induced Toxicity	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	P2	B (58)
Catequentinib Chemotherapy-Induced Toxicity	Wenjun Cheng	P2	B (57)
coq10 Chemotherapy-Induced Toxicity	Damanhour University	P2	B (57)
Decitabine Chemotherapy-Induced Toxicity	Chen Suning	P3	B (57)
Gilteritinib Chemotherapy-Induced Toxicity	Chen Suning	P3	B (57)
Lenvatinib Chemotherapy-Induced Toxicity	Sun Yat-sen University	P3	B (57)
Simvastatin Chemotherapy-Induced Toxicity	Indonesia University	P2	B (57)
Terelizumab Chemotherapy-Induced Toxicity	Daping Hospital and the Research Institute of Surgery of the Third Military Medical University	P2	B (57)
Trastuzumab Chemotherapy-Induced Toxicity	Daping Hospital and the Research Institute of Surgery of the Third Military Medical University	P2	B (57)
Venetoclax Chemotherapy-Induced Toxicity	Chen Suning	P3	B (57)
(+)-Vincristine Chemotherapy-Induced Toxicity	Instituto do Cancer do Estado de São Paulo	P2	B (57)
Donafenib Chemotherapy-Induced Toxicity	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	P2	CCC (55)
Antibody Drug Conjugate Composed Of A Humanized Monoclonal Antibody Targeting Cldn18.2 And Linker-Payload Mc-Vc-Pab-Mmae Chemotherapy-Induced Toxicity	Shanghai Zhongshan Hospital	P2	CCC (53)
Epirubicin Chemotherapy-Induced Toxicity	Zhejiang Provincial People's Hospital	P2	CCC (53)
Floxuridine Chemotherapy-Induced Toxicity	Oslo University Hospital	P2	CCC (53)
Inetetamab Chemotherapy-Induced Toxicity	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	P2	CCC (53)
Lobaplatin Chemotherapy-Induced Toxicity	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	P2	CCC (53)
Muamycin Chemotherapy-Induced Toxicity	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	P2	CCC (53)
Pegaspargase Chemotherapy-Induced Toxicity	Instituto do Cancer do Estado de São Paulo	P2	CCC (53)
Pertuzumab Chemotherapy-Induced Toxicity	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	P2	CCC (53)

Showing 1 to 50 of 63 assets

PreviousPage 1 of 2Next